1050 Heat Shock Proteins Predict Clinical Response and Potentiate Local Immunogenicity After LITT for Glioblastoma

INTRODUCTION: Even given standard of care and the advent of new therapies, glioblastoma (GBM) is one of the deadliest forms of cancer. Laser interstitial thermal therapy(LITT) is a minimally invasive technique used to ablate intra-axial brain tumors. Non-ablative LITT-induced hyperthermia (33-43°C) increases intra-tumoral mutational burden and neoantigen production. Hyperthermia promotes neoantigen presentation via release of heat shock proteins(HSPs). HSPs are protein-folding chaperones that can present novel intracellular antigens for immune recognition. METHODS: We conducted immune deconvolution of bulk RNA-sequencing data obtained from The Cancer Genome Atlas, determining the correlation between 97 HSPs and tumor infiltration of CD8+,CD4+,B,Macrophage,Neutrophil,and Dendritic cells. We evaluated the association between expression of these HSPs and overall survival(OS). Additionally, we obtained pre-LITT biopsies for 9 patients consisting of responders and non-responders and conducted immunohistochemistry to identify spatial expression of HSPs. To validate our findings, we utilized next generation sequencing to determine genomic variations of identified HSPs, as well as identify other predictive biomarkers. RESULTS: We identified two HSPs for further investigation, SACS and HSPA5. SACS was associated improved survival based on TCGA data (14.9vs.11 months,HR:1.3,p<0.0001). HSPA5 was associated with worse outcomes (12.1vs.15.0 months,HR:0.73,p<0.0001). Based on immune deconvolution, HSPA5 was positively correlated with dendritic cell infiltration (r=0.50,p=6.1E-27). SACS was positively correlated with CD8+ infiltration(SACS:r=0.31,p=6.8E-11). IHC of 9 patients stratified based on OS demonstrated high SACS expression was associated with improved OS(p<0.05) after LITT. Immune cell infiltration was associated with therapeutic response after LITT using multiplex IHC. CONCLUSIONS: As we continue our immunohistochemical and genomic analysis, we hope to clarify the role HSPs play in potentiating immunogenicity in GBM. Further investigation into SACS and immune cell infiltration may inform how hyperthermia mediates improved response to LITT via neoantigen presentation.

Authors

Publication Details

Journal
Neurosurgery
Published
2025-03-14
DOI
https://doi.org/10.1227/neu.0000000000003360_1050
Primary Topic
Heat shock proteins research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

1050 Heat Shock Proteins Predict Clinical Response and Potentiate Local Immunogenicity After LITT for Glioblastoma

Christian Ramsoomair, Shovan Bhatia, Emade Jaman, Chandler Berke et al.
Neurosurgery
Heat shock proteins research
article

1050 Heat Shock Proteins Predict Clinical Response and Potentiate Local Immunogenicity After LITT for Glioblastoma

Christian Ramsoomair, Shovan Bhatia, Emade Jaman, Chandler Berke, Victor M. Lu, Mynor Mendez Valdez, Jay Chandar, Anna Hudson, Deepa Seetharam, Jelisah Desgraves, Venkatesh Govindarajan, Jesús Castro, Michael E. Ivan, Ricardo Jorge Komota
article en

Abstract

INTRODUCTION: Even given standard of care and the advent of new therapies, glioblastoma (GBM) is one of the deadliest forms of cancer. Laser interstitial thermal therapy(LITT) is a minimally invasive technique used to ablate intra-axial brain tumors. Non-ablative LITT-induced hyperthermia (33-43°C) increases intra-tumoral mutational burden and neoantigen production. Hyperthermia promotes neoantigen presentation via release of heat shock proteins(HSPs). HSPs are protein-folding chaperones that can present novel intracellular antigens for immune recognition. METHODS: We conducted immune deconvolution of bulk RNA-sequencing data obtained from The Cancer Genome Atlas, determining the correlation between 97 HSPs and tumor infiltration of CD8+,CD4+,B,Macrophage,Neutrophil,and Dendritic cells. We evaluated the association between expression of these HSPs and overall survival(OS). Additionally, we obtained pre-LITT biopsies for 9 patients consisting of responders and non-responders and conducted immunohistochemistry to identify spatial expression of HSPs. To validate our findings, we utilized next generation sequencing to determine genomic variations of identified HSPs, as well as identify other predictive biomarkers. RESULTS: We identified two HSPs for further investigation, SACS and HSPA5. SACS was associated improved survival based on TCGA data (14.9vs.11 months,HR:1.3,p<0.0001). HSPA5 was associated with worse outcomes (12.1vs.15.0 months,HR:0.73,p<0.0001). Based on immune deconvolution, HSPA5 was positively correlated with dendritic cell infiltration (r=0.50,p=6.1E-27). SACS was positively correlated with CD8+ infiltration(SACS:r=0.31,p=6.8E-11). IHC of 9 patients stratified based on OS demonstrated high SACS expression was associated with improved OS(p<0.05) after LITT. Immune cell infiltration was associated with therapeutic response after LITT using multiplex IHC. CONCLUSIONS: As we continue our immunohistochemical and genomic analysis, we hope to clarify the role HSPs play in potentiating immunogenicity in GBM. Further investigation into SACS and immune cell infiltration may inform how hyperthermia mediates improved response to LITT via neoantigen presentation.

NeurosurgeryVol. 71(Supplement_1)
Openalex Percentile: Top 96%
Heat shock proteins research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.